Dr. Ravendhran is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
700 Geipe Rd
Ste 230
Catonsville, MD 21228Phone+1 410-247-7500Fax+1 410-247-4227
Education & Training
University of Missouri-ColumbiaFellowship, Gastroenterology, 1980 - 1982
University of Miami/Jackson Health SystemFellowship, Gastroenterology, 1979 - 1980
St Agnes HealthCareResidency, Internal Medicine, 1977 - 1979- Church Hospital CorporationInternship, Internal Medicine, 1975 - 1976
Stanley Medical College SMCClass of 1974
Certifications & Licensure
MD State Medical License 1976 - 2025
FL State Medical License 1979 - 1981- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- healing hand soceity Ascencion health services, 2019
- Fellow (AGAF) American Gastroenterological Association, 2007
- Fellow (FACG) American College of Gastroenterology
Clinical Trials
- Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection Start of enrollment: 2014 Dec 09
- Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment Start of enrollment: 2015 Sep 22
- Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects Start of enrollment: 2017 Apr 20
Publications & Presentations
PubMed
- 519 citationsEfficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infe...Paul Y. Kwo, Eric Lawitz, Jonathan McCone, Eugene R. Schiff, John M. Vierling
Lancet. 2010-08-28 - 17 citationsResistance-associated amino acid variants associated with boceprevir plus pegylated interferon-α2b and ribavirin in patients with chronic hepatitis C in the SPRINT-1 t...Robert A. Ogert, John A. Howe, John M. Vierling, Paul Y. Kwo, Eric Lawitz
Antiviral Therapy. 2013-01-01 - 43 citationsRacial differences in hepatitis C treatment eligibilityMichael T. Melia, Andrew J. Muir, Jonathan McCone, Mitchell L. Shiffman, John W. King
Hepatology. 2011-07-01
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
